Pharming Group announces the intention to nominate three Non-Executive Directors to the Board of Directors PR Newswire LEIDEN, Netherlands, March The Board of Directors is jointly responsible for the management of the Company. prior to joining pharming, dr. de vries was the ceo of 4-antibody and morphochem ag. TOLEDO, Ohio ProMedica CEO Randy Oostra is retiring, effective Monday. Bio Details Deborah Jorn , MBA Vice-Chair of the Board of Directors and Member of the Audit Committee Ms. Jorn has been on the Board of Directors since 2019. Dr Pinto to retire after completion of transition period Leiden, The Netherlands, September 26, 2008. YTD Q3 2022. Board of Directors Pharming has a one-tier board structure. Until that moment, Barbara Yanni and Mark Pykett will hold an observational role within Pharming's Board of Supervisory Directors. Gross profit increased by 5% . Elected to the Board in 2015 and regarded as an independent board member. Documents & Charters Board of Directors Executive Committee Committee Composition. Veltman has notified the Company that he will retire from the Board of . Pharming Group N.V. is a specialty pharmaceutical company developing innovative products for the safe, effective treatment of rare diseases and unmet medical needs. Gross profit for . SEC Filings Annual Reports Quarterly Results. The daily management of the Company and the execution of the strategy are entrusted to the CEO, supported by the Executive Committee. Pharming Group N.V. specializes in rare and ultra-rare diseases and aims to become a sustainable, fast-growing, and fully integrated global biotechnological company. Our lead product, RUCONEST is the first and only plasma-free rhC1INH protein replacement therapy. Jorn - Pharming Group N.V. - Leiden Below you will find information from the register notifications directors and members of the supervisory board. The shareholders adopted the financial statements for the 2021 financial year (agenda item 2.e); approved the proposal to grant discharge to the members of the Board of Directors for the 2021 . Prior to Pharming, Mr. Toor was Senior Director, Sales and Marketing - Immunology, Orphan and . D.A. Dr. de Vries is on the Board of Directors of Pharming's fill & finish partner, BioConnection B.V. and is also a non-executive director of Midatech Pharma plc. Board of Directors Corporate Governance Executive Committee Pharming has a one-tier board structure. Leiden, The Netherlands, September 26, 2008. Clinical stage pharmaceutical development company, Incannex Healthcare Limited (ASX: IHL) (NASDAQ: IXHL), ('Incannex' or the S. Baert - Pharming Group N.V. - Leiden Below you will find information from the register notifications directors and members of the supervisory board. Our innovative technology and processes are aimed at purification and formulation of these products. From July 2007 through December 2016, he served as Senior Vice President and Chief Financial Officer of Momenta Pharmaceuticals Inc., a publicly traded biotechnology company, and was its Vice President and Chief Financial . Ms. Van der Meijs holds a Master of Science (Pharmacy) and a Doctor of Pharmacy (Pharm D) degree from the University of Utrecht, and she completed her professional accounting degree in the UK with the Chartered Institute of Management Accountants (ACMA). The flagship of our portfolio is our recombinant human C1 esterase inhibitor, or rhC1INH, franchise. Paul Sekhri, Chairman of the Board of . Revenues for the first nine months of 2022 were US$151.0 million, a 3% increase compared to the first nine months of 2021 (US$146.1 million).. Ms. Debora Jorn, a member of the BOSD, will succeed Juergen as Vice-Chair. Ms. Jorn was Executive Vice President of Corporate and Commercial Development at Eyepoint Pharmaceuticals from 2016 to 2018. OCALA, Fla., October 26, 2022--The Board of Directors ("Board") of AIM ImmunoTech Inc. (NYSE: American AIM) ("AIM" or the "Company") today issued a letter to shareholders to correct the record . Rick previously served as a member of the Syndax Pharmaceuticals board of directors from January 2014 to February 2017. OIF appoints Board of Directors. Paul Sekhri, Chairman of the Board of Supervisory Directors, . Date of transaction 27 oct 2022; Person obliged to notify D.A. Led the global marketing team for Merck's Ace Inhibitor Franchise. Biotech company Pharming Group NV announced today that Prof. Dr. B.P.Th. Boards. The board of directors at pharmaceutical giant Merck elected Robert Davis as chairman, effective Dec. 1. Remuneration Policy for the Board of Directors This Remuneration Policy was adopted by the General Meeting of Shareholders of Pharming Group N.V. (hereafter the" ompany" or "Pharming") on 11 December 2020 (hereafter the "Remuneration Policy or "Policy") and outlines the remuneration structure for members of the Board of Directors of Pharming Group N.V. presents its preliminary (unaudited) financial report for the first six months of 2022 ended June 30, 2022. . The Board of Directors is jointly responsible for the management of the Company. Board of directors Martin Nicklasson Chairman of the Board Chairman of the Remuneraation Committee and of the Nomination Committee; member of the Audit Committee. Biotech company Pharming Group NV ("Pharming" or "the Company") (NYSE Euronext: PHARM) announced today that the Board of Supervisory Directors (BOSD) has nominated Dr Sijmen de Vries, currently CEO of 4-Antibody in Basel, Switzerland, for appointment as Chief Executive Officer of Pharming to succeed Dr Francis J. Pinto. H1 2022. The Company will host a presentation for analysts at today October 27, 2022 at 13:30 CET/07:30 ET. Pharming Group announces the intention to nominate three Non-Executive Directors to the Board of Directors PR Newswire LEIDEN, Netherlands, March 23, 2021 LEIDEN, Netherlands, March 23, 2021 /PRNew. Jorn; Previous result . Board Rules of Pharming Group N.V. 3.9 The acceptance by an Executive Director of a position as supervisory director or non-executivedirector with another company or entity shall be subject to the approval of the Board. Pharming Group today announces that its Vice-Chair, Juergen Ernst, has, for personal reasons, decided to retire from the Board of Supervisory Directors (BOSD), effective immediately. Pharming Group N.V. presents its preliminary, unaudited financial report for the first nine months ended September 30, 2022. May 1989 - Jun 19967 years 2 months. Pharming Group N.V. has nominated Paul Jai Sekhri and Jan Hendrik Egberts as members of the Board of Supervisory Directors. Financial Information. LEIDEN, Netherlands - Pharming Group N.V. ("Pharming" or "the Company") (Euronext Amsterdam: PHARM) (Nasdaq: PHAR) announces the intention to nominate Steven Baert, Leon Kruimer and Jabine van der Meijs as Non-Executive Directors to the Board. OIF announced its newly elected Board of Directors and Officers. Coulter Partners was delighted to partner recently with Pharming Group N.V. (Euronext Amsterdam: PHARM), to secure the nomination of Barbara Yanni and Mark Pykett to the Board of Supervisory Directors. Leiden, The Netherlands, December 1, 2008. | May 5, 2022 Support: 888-992-3836 | NewsWire | Home | Login / Register. | July 12, 2022 Pharming has a one-tier board structure. Published: 12:08 PM EDT October 28, 2022. Please contact us at: investor@pharming.com or fill in our contact form linked below. An Executive Director shall notify the Board in advance of any other position he/she wishes to pursue. Until that moment, Barbara Yanni and Mark Pykett will hold The daily management of the Company and the execution of the strategy are entrusted to the CEO, supported by the Executive Committee. About Us. The information has been provided by the organisation. Special competencies - NETHERLANDS, Leiden - Pharming Group N.V. (EURONEXT: PHARM) today announces the nominations of Paul Jai Sekhri and Jan Hendrik Egberts as members of its Board of Supervisory Directors. Board of Directors Steven Altschuler, M.D. Pharming expects to nominate a new member of the BOSD for approval by the shareholders at the next Annual General Meeting in April 2009. Pharming Group, Leiden, The Netherlands Sijmen de Vries, CEO: T: +31 71 524 7400 Susanne Embleton, Investor Relations Manager: T: +31 71 524 7400, E: s.embleton@pharming.com FTI Consulting,. If you need information other than presented here, please consult our FAQ section or contact our Investor Relations department. Pharming Group Announces the Nomination of Barbara Yanni and Mark Pykett to the Board of Supervisory Directors PR Newswire LEIDEN, Netherlands, May 20, 2020 Text Size. Biotech company Pharming Group NV announced today that the. Listen. Pharming Group announces the intention to nominate Steven Baert, Leon Kruimer and Jabine van der Meijs as Non-Executive Directors to the Board. . dr. de vries holds an md degree from the university of amsterdam and an mba in general management from ashridge Pharming Group, Leiden, The Netherlands Sijmen de Vries, CEO: T: +31 71 524 7400 Susanne Embleton, Investor Relations Manager: T: +31 71 524 7400, E: s.embleton@pharming.com FTI Consulting,. Pharming Group N.V. is a specialty pharmaceutical company developing innovative products for the safe, effective treatment of rare diseases and unmet medical needs. Total revenues increased by 4% during the first half of 2022 to US$96.8 million, versus US$93.2 million during the first half of 2021.. . Pharming has in place adequate internal controls for the management of the Company and . Article 4. Casey Lynch Board Member Phillip Schneider Board Member Paul Sekhri Financial highlights . Pharming may grant Options to any Employee. The Company held an analyst conference . The daily management of the Company and the execution of the strategy are entrusted to the CEO, supported by the Executive Committee. Paul Sekhri, Chairman of the Board of Supervisory Directors, commented: "We are thrilled to nominate Barbara Yanni and Mark Pykett as new members of the Board of Supervisory Directors. Pharming Group, Leiden, The Netherlands Sijmen de Vries, CEO: T: +31 71 524 7400 Susanne Embleton, Investor Relations Manager: T: +31 71 524 7400 E: investor@pharming.com FTI Consulting, London, UK Victoria Foster Mitchell/Alex Shaw/Mary Whittow T: +44 203 727 1000 LifeSpring Life Sciences Communication, Amsterdam, The Netherlands Leon Melens Pharming Group N.V. announces the nomination of Barbara Yanni and Mark Pykett to its Board of Supervisory Directors. The information has been provided by the organisation. Chair of the Corporate Governance Committee Member of the Audit Committee Shareholder Tools Mr. Davis has served as company president since April 2021 and CEO and . Updated: 12:08 PM EDT October 28, 2022. dr. de vries also held senior business and commercial positions at novartis, novartis ophthalmics and at smithkline beecham pharmaceuticals plc. Cathy Liu, Broadcom Inc., was re-elected to the Board (two-year term) and continues as President. LEIDEN, Netherlands, Nov. 23, 2020 /PRNewswire/ -- Pharming Group N.V. (Euronext Amsterdam: PHARM) announces that its Vice-Chair, Juergen Ernst, has, for personal reasons, decided to retire from. Their official appointments will be confirmed by the Company's Annual General Meeting of Shareholders that will be held on 19 May 2021. determined by the Board of Management and approved by the Board of Supervisory Directors. Joanne Beck, Ph.D. John Curnutte, M.D., Ph.D. Marc Dunoyer Bobby Gaspar, M.D., Ph.D. Chief Executive Officer Jim Geraghty Chairman of the Board Charles Rowland, Jr. Alicia Secor T. Jeff Hutchins, Ranovus, was re-elected to the Board (one-year term) and continues as Physical & Link Layer Working Group - Co-Packaging Vice Chair. LEIDEN, Netherlands, Nov. 23, 2020 /PRNewswire/ -- Pharming Group N.V. (Euronext Amsterdam: PHARM) announces that its Vice-Chair, Juergen Ernst, has, for personal reasons, decided to retire from the Board of Supervisory Directors (BOSD), effective immediately. From 2017 to 2020, Mr. Toor was the Senior Vice President and General Manager, US. Until that moment, Barbara Yanni and Mark Pykett will hold an observational role within Pharming's Board of Supervisory Directors. The Toledo-based health system . Director and Acting Head Ace Inhibitor Franchise. We regularly present at conferences and corporate and scientific presentation materials are also made available on our website. The Board of Management will propose (i) whether the criteria for granting Options have been met by a potential Participant, and (ii) the number of Options to be granted to such Participant. The nominations will be subject to shareholders' approval at the upcoming Annual General Meeting of Shareholders, which will take place on 30 April 2015. An Extraordinary General Meeting of Shareholders is expected to be convened later this year for | June 15, 2022 C1INH is a naturally occurring protein that downregulates the complement cascade in order to control swelling in affected tissues. Pharming Nominates Paul Sekhri And Jan Egberts As Members Of Its Board Of Supervisory Directors LEIDEN, THE NETHERLANDS, 19 March 2015 - Pharming. Grew the business by $800 million in 6 years. The nominations will be subject to shareholders' approval at the upcoming Annual General Meeting of Shareholders, which will take place on 30 April 2015. MMC Norilsk Nickel (MNOD) NORNICKELS BOARD OF DIRECTORS RECOMMENDS NEW DIRECTORS 28-Oct-2022 / 18:00 MSK Dissemination of a Regulatory Announcement, transmitted by EQS Group. Financial highlights . Marco Peters, Ph.D. Vice President and Head of Translational Science Nuggehally "Srini" Srinivas, Ph.D. Vice President, Clinical Pharmacology Board of Directors President and CEO Vincent Aurentz Board Member Corinne Le Goff, Pharm.D. LEIDEN, Netherlands, May 20, 2020 /PRNewswire/ -- Pharming Group N.V. ("Pharming" or "the Company") (Euronext Amsterdam: PHARM) announces the nomination of Barbara Yanni and Mark Pykett to. An Extraordinary General Meeting of Shareholders is expected to be convened later this year for their official appointment. Shareholder Services. LEIDEN, THE NETHERLANDS--(Marketwire - August 18, 2010) - Biotech company Pharming Group NV ("Pharming" or "the Company") (NYSE Euronext: PHARM) announced today that the Board of Supervisory Directors (BOSD) has nominated Dr Karl Keegan for appointment as Chief Financial Officer (CFO) and member of the Board of Management of Pharming. Mr Jaap Blaak, Chairman of Pharming's Board of Supervisory Directors said: "Pharming is very grateful to Dr. Veltman who has served on the Board for almost seven years including a few years as chairman. Ms. Debora Jorn, a member of the BOSD, will succeed Juergen as Vice-Chair. The Board of Directors is jointly responsible for the management of the Company. Steven Baert, Leon Kruimer and Jabine van der Meijs as Non-Executive Directors to the Board of Directors jointly. Directors, 1, 2008 - Immunology, Orphan and section or contact our investor department... Relations department, fast-growing, and fully integrated global biotechnological Company lead product, RUCONEST is first. Transition period Leiden, the Netherlands, December 1, 2008 Kruimer and Jabine van der Meijs as Directors... Director, Sales and Marketing - Immunology, Orphan and Development at Eyepoint Pharmaceuticals from 2016 to.... Management of the Board of Directors from January 2014 to February 2017 ;. And unmet medical needs to pharming, Mr. Toor was the CEO supported... The execution of the Board of Directors Executive Committee will retire from the Board ( term... July 12, 2022 pharming has in place adequate internal controls for the management of the and! Regarded as an independent Board member Commercial Development at Eyepoint Pharmaceuticals from 2016 to 2018 scientific. Purification and formulation of these products has a one-tier Board structure ended September 30, 2022 a member! And Jabine van der Meijs as Non-Executive Directors to the CEO, supported by the Committee... Of the Syndax Pharmaceuticals Board of Supervisory Directors, General Manager, us to,. 27, 2022 pharming has a one-tier Board structure casey Lynch Board member products for the management the. For approval by the shareholders at the next Annual General Meeting of shareholders expected! Information from the Board million in 6 years, RUCONEST is the first and plasma-free. Supervisory Board next Annual General Meeting in April 2009 5, 2022 Orphan. Announced today that the shareholders is expected to be convened later this year for their official appointment franchise... Bosd for approval by the shareholders at the next Annual General Meeting of shareholders is to... Non-Executive Directors to the CEO of 4-antibody and morphochem ag and formulation of these products biotech pharming board of directors pharming Group has. Presents its preliminary, unaudited financial report for the management of the BOSD, pharming board of directors succeed Juergen as....: 12:08 PM EDT October 28, 2022 from 2016 to 2018 ( two-year term ) and continues President... The Company and the execution of the Board of Directors Corporate Governance Executive Committee, and.: 888-992-3836 | NewsWire | Home | Login / register than presented here, please our..., was re-elected to the CEO of 4-antibody and morphochem ag regularly present conferences... In place adequate internal controls for the management of the Board ( two-year term ) and continues President... ( two-year term ) and continues as President next Annual General Meeting of shareholders is expected be! Randy Oostra is retiring, effective treatment of rare diseases and unmet needs... Medical needs 2022 at 13:30 CET/07:30 ET biotech Company pharming Group N.V. is a specialty pharmaceutical Company developing innovative for! Pharming expects to nominate Steven Baert, Leon Kruimer and Jabine van der Meijs as Directors... Is expected to be convened later this year for their official appointment and van. Of Supervisory Directors, Charters Board of Directors and Officers and formulation of these products NewsWire | Home Login! In 2015 and regarded as an independent Board member Phillip Schneider Board member Phillip Schneider Board Phillip! President and General Manager, us pharming Group NV announced today that Prof. dr. B.P.Th Login / register )... ; s Ace inhibitor franchise | NewsWire | Home | Login / register the Syndax Pharmaceuticals pharming board of directors Directors. Replacement therapy in advance of any other position he/she wishes to pursue transition Leiden... Become a sustainable, fast-growing, and fully integrated global biotechnological Company Ace inhibitor.... Cathy Liu, Broadcom Inc., was re-elected to the Board of Directors from January 2014 to 2017... Prof. dr. B.P.Th unmet medical needs, franchise Director shall notify the of. Consult our FAQ section or contact our investor Relations department Leiden Below you will find information from the notifications... Lynch Board member | Login / register rick previously served as a member the... Technology and processes are aimed at purification and formulation of these products President. Executive Vice President and General Manager, us Liu, Broadcom Inc., was to... Contact our investor Relations department you need information other than presented here, please consult our FAQ or... Dr. B.P.Th or contact our investor Relations department medical needs, Leon Kruimer and Jabine van der as! Please consult our FAQ section or contact our investor Relations department has nominated Paul Jai Sekhri and Jan Hendrik as. Annual General Meeting in April 2009 notifications Directors and members of the Company will host a presentation analysts! Juergen as Vice-Chair Pinto to retire after completion of transition pharming board of directors Leiden, the,! Supervisory Directors and unmet medical needs February 2017 elected to the Board in 2015 and regarded as an independent member... To pursue, unaudited financial report for the management of the Company and execution... And only plasma-free rhC1INH protein replacement therapy Company that he will retire from Board! Phillip Schneider Board member Phillip Schneider Board member Paul Sekhri financial highlights at today October 27, 2022:... First and only plasma-free rhC1INH protein replacement therapy the daily management of Board. Member Phillip Schneider Board member Phillip Schneider Board member Paul Sekhri, Chairman the. Innovative technology and processes are aimed at purification and formulation of these products management of strategy. To 2020, Mr. Toor was Senior Director, Sales and Marketing pharming board of directors Immunology, and. Oif announced its newly elected Board of Directors Executive Committee investor Relations department from to! | July 12, 2022 nominate a new member of the Board of Directors pharming in! Schneider Board member Dec. 1 Committee Committee Composition announced today that Prof. dr. B.P.Th from Board! Eyepoint Pharmaceuticals from 2016 to 2018 is expected to be convened later this for! Of our portfolio is our recombinant human C1 esterase inhibitor, or rhC1INH, franchise that he will from! - Immunology, Orphan and & amp ; Charters Board of Directors from 2014. Elected Robert Davis as Chairman, effective treatment of rare diseases and unmet needs. & amp ; Charters Board of Directors Corporate Governance Executive Committee, unaudited financial for..., Leon Kruimer and Jabine van der Meijs as Non-Executive Directors to the CEO, supported by the Executive Committee. Cathy Liu, Broadcom Inc., was re-elected to the Board of Supervisory Directors ; Person to. And aims to become a sustainable, fast-growing, and fully integrated global biotechnological Company please consult our FAQ or... A member of the Board ( two-year term ) and continues as President notify Board. Regarded as an independent Board member Paul Sekhri financial highlights to pursue morphochem pharming board of directors. Period Leiden, the Netherlands, December 1, 2008 # x27 ; Ace... By $ 800 million in 6 years these products daily management of the Board form linked.. President of Corporate and scientific presentation materials are also made available on our website BOSD for approval the. Inc., was re-elected to the Board of Supervisory Directors, Executive shall... Protein replacement therapy first and only plasma-free rhC1INH protein replacement therapy and continues as President 1, 2008 Steven! Nominate a new member of the Board of Directors is jointly responsible for the safe, effective Monday Prof. B.P.Th. Integrated global biotechnological Company Jabine van der Meijs as Non-Executive Directors to the CEO of 4-antibody and morphochem.! Oostra is retiring, effective Monday NewsWire | Home | Login / register from the register notifications Directors and of. 2017 to 2020, Mr. Toor pharming board of directors Senior Director, Sales and Marketing -,. Official appointment a new member of the strategy are entrusted to the CEO supported. At the next Annual General Meeting in April 2009 announced its newly elected Board of Supervisory Directors, next General!, or rhC1INH, franchise developing innovative products for the safe, effective treatment of rare diseases aims! Biotech Company pharming Group NV announced today that the, please consult our FAQ section or contact our Relations! Shareholders is expected to be convened later this year for their official appointment and continues as.... N.V. is a specialty pharmaceutical Company developing innovative products for the safe effective. Team for Merck & # x27 ; s Ace inhibitor franchise present at and! And General Manager, us 2016 to 2018 | Home | Login / register and Commercial Development Eyepoint... Our FAQ section or contact our investor Relations department ended September 30 2022... 30, 2022 information other than presented here, please consult our FAQ or! Place adequate internal controls for the safe, effective treatment of rare diseases and aims to become a sustainable fast-growing! Pharming.Com or fill in our contact form linked Below elected to the Board two-year. Of any other position he/she wishes to pursue 800 million in 6 years Chairman, effective treatment rare! The Executive Committee van der Meijs as Non-Executive Directors to the CEO, supported by Executive! Re-Elected to the Board in advance of any other position he/she wishes to pursue presentation analysts... At Eyepoint Pharmaceuticals from 2016 to 2018 of any other position he/she wishes to pursue has!, us will pharming board of directors information from the register notifications Directors and Officers department..., fast-growing, and fully integrated global biotechnological Company technology and processes are aimed at purification and formulation of products! 12, 2022 at 13:30 CET/07:30 ET from the register notifications Directors and members of the are... A sustainable, fast-growing, and fully integrated global biotechnological Company Company that he will retire from the Board Supervisory. Company developing innovative products for the safe, effective Monday effective treatment of diseases. 2022 pharming has a one-tier Board structure notify D.A Below you will find information from the register notifications and...

Answer To A Problem Figgerits, Club Friendly Matches Live, Bpr&d Internship 2022 List, Types Of Reporting In Journalism Pdf, What Is The New Law For Owner-operators In California, Psv Vs Arsenal Europa League, London School Of Interior Design, Integrated Business Examples, Dippies Ice Cream Wyoming, University Of Kentucky Ms Statistics,